2025
The association between cannabis use and paranoia: Meta-analysis of experimental and observational studies
Belvederi Murri M, Catania S, Centra S, Folesani F, Muscettola A, Zerbinati L, Toffanin T, Ferrara M, Ossola P, Rossi R, Jannini T, Caruso R, Nanni M, Grassi L. The association between cannabis use and paranoia: Meta-analysis of experimental and observational studies. Neuroscience & Biobehavioral Reviews 2025, 176: 106269. PMID: 40578496, DOI: 10.1016/j.neubiorev.2025.106269.Peer-Reviewed Original ResearchConceptsParanoid symptomsCannabis useBayesian model-averaged meta-analysisStandardized mean differencePsychiatric disordersEffect size measuresObservational studyBayesian meta-analysesMeta-analysisOdds ratioCannabinoid useCannabinoid usersCannabinoidParanoiaCannabisTherapeutic actionCross-sectional studyBayesian meta-analysisSymptomsPooled effectMeta-analysesGeneral populationMean differenceNon-usersProspective study
2013
Prediction of Psychopathology and Functional Impairment by Positive and Negative Schizotypy in the Chapmans’ Ten-Year Longitudinal Study
Kwapil T, Gross G, Silvia P, Barrantes-Vidal N. Prediction of Psychopathology and Functional Impairment by Positive and Negative Schizotypy in the Chapmans’ Ten-Year Longitudinal Study. Journal Of Psychopathology And Clinical Science 2013, 122: 807-815. PMID: 24016018, DOI: 10.1037/a0033759.Peer-Reviewed Original ResearchConceptsNegative schizotypyPredictive validityPrediction of psychopathologyLongitudinal dataTen-year longitudinal studyNegative symptom dimensionsSchizophrenia spectrum disordersMental health treatmentPoor adjustmentSocial impairmentValidity findingsSchizoid symptomsRecent cross-sectional studySchizotypyCross-sectional studySymptom dimensionsControl participantsDevelopment of schizophreniaPositive dimensionUseful constructHealth treatmentParanoid symptomsMultidimensional structureLongitudinal studyDifferential patterns
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply